Unknown

Dataset Information

0

Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls.


ABSTRACT: Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO2peak) as a result of pulmonary, pulmonary vascular, or cardiac insult. This study examined whether cardiopulmonary mechanisms could explain exertional dyspnea in Long-CoV. Methods: A cross-sectional study of participants with Long-CoV (n = 28, age 40 ± 11 years, 214 ± 85 days post-infection) and age- sex- and body mass index-matched COVID-19 naïve controls (Con, n = 24, age 41 ± 12 years) and participants fully recovered from COVID-19 (ns-CoV, n = 14, age 37 ± 9 years, 198 ± 89 days post-infection) was conducted. Participants self-reported symptoms and baseline dyspnea (modified Medical Research Council, mMRC, dyspnea grade), then underwent a comprehensive pulmonary function test, cardiopulmonary exercise test, exercise pulmonary diffusing capacity measurement, and rest and exercise echocardiography. Results: VO2peak, pulmonary function and cardiac/pulmonary vascular parameters were not impaired in Long- or ns-CoV compared to normative values (VO2peak: 106 ± 25 and 107 ± 25%predicted, respectively) and cardiopulmonary responses to exercise were otherwise normal. When Long-CoV were stratified by clinical dyspnea severity (mMRC = 0 vs mMRC≥1), there were no between-group differences in VO2peak. During submaximal exercise, dyspnea and ventilation were increased in the mMRC≥1 group, despite normal operating lung volumes, arterial saturation, diffusing capacity and indicators of pulmonary vascular pressures. Interpretation: Persistent dyspnea after COVID-19 was not associated with overt cardiopulmonary impairment or exercise intolerance. Interventions focusing on dyspnea management may be appropriate for Long-CoV patients who report dyspnea without cardiopulmonary impairment.

SUBMITTER: Beaudry RI 

PROVIDER: S-EPMC9297912 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls.

Beaudry Rhys I RI   Brotto Andrew R AR   Varughese Rhea A RA   de Waal Stephanie S   Fuhr Desi P DP   Damant Ronald W RW   Ferrara Giovanni G   Lam Grace Y GY   Smith Maeve P MP   Stickland Michael K MK  

Frontiers in physiology 20220706


<b>Background:</b> Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO<sub>2peak</sub>) as a result of pulmonary, pulmonary vascular, or cardiac insult. This study examined whether cardiopulmonary mechanisms could explain exertional dyspnea in Long-CoV. <b>Methods:</b> A cross-sectional study of participants with Long-CoV (n = 28, age 40  ...[more]

Similar Datasets

| S-EPMC10846960 | biostudies-literature
| S-EPMC8075707 | biostudies-literature
| S-EPMC9024358 | biostudies-literature
| S-EPMC8775030 | biostudies-literature
| S-EPMC8998214 | biostudies-literature
| S-EPMC10997262 | biostudies-literature
| S-EPMC8318328 | biostudies-literature
| S-EPMC9200639 | biostudies-literature
| S-EPMC7392684 | biostudies-literature
| S-EPMC10102893 | biostudies-literature